Patients infected with hepatitis B virus (HBV) and HIV, with evidence of immunosuppression, have a poorer response to interferon-alfa therapy than patients who are only infected with HBV, according to a report published in the December issue of Gastroenterology.
Still, interferon-alfa therapy does appear to reduce the risk of HBV cirrhosis in patients with HIV coinfection.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!